Literature DB >> 8083666

Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum.

T F Schwarz1, S Wiersbitzky, M Pambor.   

Abstract

We report the findings on a skin biopsy taken from a child acutely infected with parvovirus B19 showing the typical exanthematous rash. By indirect immunofluorescence with a monoclonal antibody to B19, viral capsid proteins were detected in epidermal cells localized mainly in the stratum basale. Additionally, B19 DNA was detected in epidermal cells of the stratum basale by in situ hybridization using a Dig-labelled B19 DNA probe. The detection of viral capsid proteins and viral DNA suggests the presence of complete viral particles. It is therefore concluded that B19 plays a direct role in the formation of the exanthematous rash in erythema infection.

Entities:  

Mesh:

Year:  1994        PMID: 8083666     DOI: 10.1002/jmv.1890430214

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Detection of parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis.

Authors:  S Nikkari; H Lappalainen; R Saario; K Lammintausta; P Kotilainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors:  K A Weigel-Kelley; M C Yoder; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection.

Authors:  J R Kerr; M McCoy; B Burke; D L Mattey; V Pravica; I V Hutchinson
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 6.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 7.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions.

Authors:  Itsuro Kazama; Naoko Sasagawa; Toshiyuki Nakajima
Journal:  Case Rep Med       Date:  2012-04-24

Review 9.  Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature.

Authors:  Yujin Kobayashi; Yoshihiro Hatta; Yusaku Ishiwatari; Hitoshi Kanno; Masami Takei
Journal:  BMC Res Notes       Date:  2014-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.